Skip to main content
TipRanks
Go Ultimate75% OFF

Bernard Kasten Insider Profile

4 Followers

Bernard Kasten, Director at Statera BioPharma, holds 42.78K shares in Enzo Biochem (Ticker: ENZB), holds 27.00K shares in Statera BioPharma (Ticker: STAB). Most recently, Bernard Kasten Sold ― shares of Enzo Biochem on Mar 18, 2016 for an estimated value of $171.24K.

Bernard Kasten's Trading History

ENZB
Enzo Biochem
Mar 18, 2016―Informative Sell171.24K$29.86K
STAB
Statera BioPharma
Jun 28, 2012DirectorUninformative Buy――

You May Also Like

Bernard Kasten insider profile FAQ

What is the percentage of profitable transactions made by Bernard Kasten?
The percentage of profitable transactions made by Bernard Kasten is 50%.
What is the average return per transaction made by Bernard Kasten?
The average return per transaction made by Bernard Kasten is -27.40%.
What stocks does Bernard Kasten hold?
Bernard Kasten holds: STAB, ENZB stocks.
What was Bernard Kasten’s latest transaction?
Bernard Kasten’s latest transaction was an Informative Sell of $171.24K.
What was Bernard Kasten's most profitable transaction?
Bernard Kasten’s most profitable transaction was an Informative Sell of ENZB stock on November 12, 2014. The return on the trade was 11.90%.
What is Bernard Kasten's role in Statera BioPharma?
Bernard Kasten's role in Statera BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.